Supply Chain Intelligence

Cellectar Biosciences, Inc. Supply Chain

CLRB supply chain intelligence for Cellectar Biosciences, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

CLRB ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

5Suppliers
2Customers
3Debt Items
20Related Chains

Cellectar Biosciences, Inc. Suppliers

TickerNameConfidenceEvidence
CAMPUS-100-LLC CAMPUS-100-LLC 90% Under the Second Amended HQ Lease, which was accounted for as a modification of the initial lease and went into effect upon the landlord’s delivery of the expanded space in March 2026, the Company wi…
IONETIX-CORPORATION IONETIX-CORPORATION 90% In December 2025, the Company announced a multi-year supply agreement with Ionetix Corporation for two critical alpha-emitting radioisotopes: Actinium-225 (Ac-225) and Astatine-211 (At-21).
SPECTRONRX SPECTRONRX 80% The finished PRCs are currently supplied by either AtomVie or SpectronRx.
ORANY ORANY 72% we experience unanticipated problems with our products, we may be subject to penalties, we may be unable to generate revenue from the sale of such products, our potential for generating positive cash…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from CLRB graph: we experience unanticipated problems with our products, we may be subject to penalties, we may be unable to generate…

Cellectar Biosciences, Inc. Customers

TickerNameConfidenceEvidence
ORANY ORANY 72% o conduct clinical trials, including full or partial clinical holds on ongoing or planned trials; ● restrictions on product manufacturing processes; ● restrictions on the marketing of a product; ● re…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from CLRB graph: o conduct clinical trials, including full or partial clinical holds on ongoing or planned trials; ● restrictions on …

Cellectar Biosciences, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CLRB-DEBT-8696 Warrants outstanding: 3032892 90% xbrl warrant detail from xbrl 2026-03-31.
CLRB-DEBT Debt stack $1.5M 90% Market cache reports total debt of $1.5M.
CLRB-DEBT-8697 Xbrl Convertible 90% xbrl convertible detail from xbrl 2023-12-31.

Cellectar Biosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Cellectar Biosciences, Inc..

Cellectar Biosciences, Inc. Ownership

HolderNameConfidenceEvidence
CLRB-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 19 tracked holders.

Cellectar Biosciences, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CATX Perspective Therapeutics, Inc. 100.00 2
SNSE Sensei Biotherapeutics, Inc. 100.00 2
RADX Radiopharm Theranostics Limited 100.00 2
DRTS Alpha Tau Medical Ltd. 100.00 2
BSX Boston Scientific Corporation 100.00 2
ATNM Actinium Pharmaceuticals, Inc. 100.00 2
ORANY ORANGE 100.00 1 ['customer', 'supplier']
JANX Janux Therapeutics, Inc. 100.00 2
LNTH Lantheus Holdings, Inc. 100.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
FENC Fennec Pharmaceuticals Inc. 50.00 2
AMZE Amaze Holdings, Inc. 50.00 2
AUMN Golden Minerals Company 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
ED Consolidated Edison, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
View CLRB supply chain intel →

Explore the full interactive supply chain map for Cellectar Biosciences, Inc..

Open CLRB supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map